These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6689423)
1. Central nervous system involvement in American Burkitt's lymphoma. Sariban E; Edwards B; Janus C; Magrath I J Clin Oncol; 1983 Nov; 1(11):677-81. PubMed ID: 6689423 [TBL] [Abstract][Full Text] [Related]
2. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica. Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699 [TBL] [Abstract][Full Text] [Related]
3. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. Murphy SB; Bowman WP; Abromowitch M; Mirro J; Ochs J; Rivera G; Pui CH; Fairclough D; Berard CW J Clin Oncol; 1986 Dec; 4(12):1732-9. PubMed ID: 3491184 [TBL] [Abstract][Full Text] [Related]
4. Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children. Spreafico F; Massimino M; Luksch R; Casanova M; Cefalo GS; Collini P; Ferrari A; Polastri D; Terenziani M; Gasparini M; Fossati-Bellani F J Clin Oncol; 2002 Jun; 20(12):2783-8. PubMed ID: 12065554 [TBL] [Abstract][Full Text] [Related]
5. An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. Magrath IT; Janus C; Edwards BK; Spiegel R; Jaffe ES; Berard CW; Miliauskas J; Morris K; Barnwell R Blood; 1984 May; 63(5):1102-11. PubMed ID: 6546890 [TBL] [Abstract][Full Text] [Related]
6. Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma. Moser AM; Adamson PC; Gillespie AJ; Poplack DG; Balis FM Cancer; 1999 Jan; 85(2):511-6. PubMed ID: 10023723 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of moderate dose combination chemotherapy in Burkitt's lymphoma. Patel JG; Pandita R; al-Jazzaf H; Mechl Z; al-Jarallah MA Neoplasma; 1993; 40(3):185-8. PubMed ID: 8350967 [TBL] [Abstract][Full Text] [Related]
9. Massive chemotherapy and autologous bone marrow transplantation in Burkitt's lymphoma: the first two patients successfully treated in Thailand. Suvatte V; Issaragrisil S; Chandanayingyong D; Mahasandana C; Tanphaichitr VS; Jirapinyo P J Med Assoc Thai; 1990 Oct; 73(10):572-80. PubMed ID: 2280205 [TBL] [Abstract][Full Text] [Related]
10. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis. Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E; Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036 [TBL] [Abstract][Full Text] [Related]
11. Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types). Bernstein JI; Coleman CN; Strickler JG; Dorfman RF; Rosenberg SA J Clin Oncol; 1986 Jun; 4(6):847-58. PubMed ID: 3711961 [TBL] [Abstract][Full Text] [Related]
12. Ophthalmoparesis due to Burkitt's lymphoma following cardiac transplantation. Liu GT; Kay MD; Byrne GE; Glaser JS; Schatz N Neurology; 1993 Oct; 43(10):2147-9. PubMed ID: 8413988 [No Abstract] [Full Text] [Related]
13. Excessive spinal cord toxicity from intensive central nervous system-directed therapies. Watterson J; Toogood I; Nieder M; Morse M; Frierdich S; Lee Y; Moertel CL; Priest JR Cancer; 1994 Dec; 74(11):3034-41. PubMed ID: 7954266 [TBL] [Abstract][Full Text] [Related]
14. Massive therapy and autologous bone marrow transplantation in very bad prognosis Burkitt's lymphoma. Philip T; Biron P; Philip I; Favrot M; Souillet G; Philippe N; Hervé P; Plouvier E; Bernard JL; Raybaud C IARC Sci Publ; 1985; (60):419-34. PubMed ID: 3905593 [TBL] [Abstract][Full Text] [Related]
15. Intrathecal chemoprophylaxis in the prevention of central nervous system relapse in Burkitt's lymphoma. Nkrumah FK; Neequaye JE; Biggar R Cancer; 1985 Jul; 56(2):239-42. PubMed ID: 3839158 [TBL] [Abstract][Full Text] [Related]
16. Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma. Morra E; Lazzarino M; Inverardi D; Brusamolino E; Orlandi E; Canevari A; Pagnucco G; Bernasconi C J Clin Oncol; 1986 Aug; 4(8):1207-11. PubMed ID: 3461134 [TBL] [Abstract][Full Text] [Related]
17. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission. Singhal S; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Mehta J Bone Marrow Transplant; 1996 Apr; 17(4):637-41. PubMed ID: 8722368 [TBL] [Abstract][Full Text] [Related]
18. [Clinical study of 40 children with Burkitt's and Burkitt-like lymphoma]. Zhang YH; Duan YL; Yang J; Jin L; Zhou CJ; Gao ZF Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):209-14. PubMed ID: 19099711 [TBL] [Abstract][Full Text] [Related]
19. Central nervous system (CNS) leukemia: the role of high dose cytarabine (HDAra-C). Morra E; Lazzarino M; Alessandrino EP; Inverardi D; Regazzi Bonora M; Pagnucco G; Orlandi E; Bernasconi P; Canevari A; Rondanelli R Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():101-3. PubMed ID: 2713552 [TBL] [Abstract][Full Text] [Related]
20. High-dose cyclophosphamide and intermediate-dose methotrexate for the treatment of far-advanced Burkitt's lymphoma. Brecher ML; Gardner RV; Ettinger LJ; Tebbi CK; Green DM; Freeman AI Am J Pediatr Hematol Oncol; 1985; 7(2):117-24. PubMed ID: 3842557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]